Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (HKG:2315)
Hong Kong
· Delayed Price · Currency is HKD 32.20
+1.22 (3.94%)
Dec 5, 2025, 4:09 PM HKT
Revenue by Product
Fiscal year is January - December.
Year Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | NaN - NaN |
|---|---|---|---|---|---|---|
| Animal Models Selling | 421.99M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Animal Models Selling Growth | 39.99% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Antibody Development | 344.56M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Antibody Development Growth | 77.30% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Pre-clinical Pharmacology and Efficacy Evaluation | 217.92M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Pre-clinical Pharmacology and Efficacy Evaluation Growth | 1.97% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Gene-editing | 78.15M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Gene-editing Growth | -4.84% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other | 415.26K |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Growth | -27.17% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other | 415.26K |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Growth | -27.17% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is January - December.
Year Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | NaN - NaN |
|---|---|---|---|---|---|---|
| Other | 182.00M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Growth | 53.74% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| United States | 536.02M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| United States Growth | 61.07% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| China | 345.00M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| China Growth | 1.17% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other | 182.00M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Growth | 53.74% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| South Korea | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|